CNCR vs. BITQ

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and BITQ (Bitwise Crypto Industry Innovators ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while BITQ is a Technology Equities fund tracking the Bitwise Crypto Innovators 30 Total Return. Both are passively managed. CNCR charges 0.79%/yr vs 0.85%/yr for BITQ.

Performance

CNCR vs. BITQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Bitwise Crypto Industry Innovators ETF (BITQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BITQ

• 1D: -1.38%
• 1M: 17.44%
• YTD: 42.95%
• 6M: 29.09%
• 1Y: 70.80%
• 3Y*: 59.75%
• 5Y*: 5.67%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. BITQ - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
BITQ Bitwise Crypto Industry Innovators ETF	48.46%

CNCR vs. BITQ - Sectors Allocation Comparison

Sectors	CNCR	BITQ
Healthcare	96.6%	-
Financial Services	3.3%	67.1%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	4.8%
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	28.1%
Utilities	-	-

Return for Risk

CNCR vs. BITQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BITQ

BITQ Risk / Return Rank: 33
BITQ Sharpe Ratio Rank: 35
BITQ Sortino Ratio Rank: 36
BITQ Omega Ratio Rank: 33
BITQ Calmar Ratio Rank: 34
BITQ Martin Ratio Rank: 26

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. BITQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Bitwise Crypto Industry Innovators ETF (BITQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	BITQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.27	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.08	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.08	—

Drawdowns

CNCR vs. BITQ - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum BITQ drawdown of -90.32%. Use the drawdown chart below to compare losses from any high point for CNCR and BITQ.

Drawdown Indicators

	CNCR	BITQ	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-90.32%	+90.32%
Max Drawdown (1Y) Largest decline over 1 year	—	-44.99%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-51.22%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-90.32%	—
Current Drawdown Current decline from peak	0.00%	-12.12%	+12.12%
Average Drawdown Average peak-to-trough decline	0.00%	-52.83%	+52.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	21.31%	—

Volatility

Volatility by Period

	CNCR	BITQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	14.70%	—
Volatility (6M) Calculated over the trailing 6-month period	—	42.75%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	56.10%	-56.10%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	67.17%	-67.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	67.25%	-67.25%

CNCR vs. BITQ - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than BITQ's 0.85% expense ratio.

Dividends

CNCR vs. BITQ - Dividend Comparison

Neither CNCR nor BITQ has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
BITQ Bitwise Crypto Industry Innovators ETF	0.00%	0.00%	0.90%	1.51%	0.00%	3.12%
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Which ETF is better, CNCR or BITQ?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or BITQ?

CNCR is cheaper with a 0.79% expense ratio, compared with 0.85% for BITQ.

Which ETF pays a higher dividend yield, CNCR or BITQ?

CNCR and BITQ have nearly identical dividend yields, around 0.00%.

What is the main difference between CNCR and BITQ?

CNCR is categorized as Health & Biotech Equities, while BITQ is Technology Equities. CNCR tracks Loncar Cancer Immunotherapy Index, while BITQ tracks Bitwise Crypto Innovators 30 Total Return. Their fees differ too: 0.79% for CNCR and 0.85% for BITQ.